Interventional oncologists often report that they have difficulty making the case for continuing to perform lung ablation, but many clinicians are convinced that lung ablation should remain within the scope of practice. | Read More
Some patients with unresectable hepatocellular carcinoma (HCC) have prolonged survival after treatment with yttrium-90 radioembolization. | Read More
The study assessed whether patients with unresectable ICC can benefit from transarterial Y-90 glass microsphere radioembolization. | Read More
Researchers conducted a prospective, single-center, double-blind randomized phase III trial that compared stable and unstable water-in-oil emulsions for chemoembolization. | Read More

Ziv Haskal, MD, introduces thyroid ablation, an important procedure that will increasingly be performed by interventional radiologists. 

| Read More

Spotlight

Interventional oncologists often report that they have difficulty making the case for continuing to perform lung ablation, but many clinicians are convinced that lung ablation should remain within the scope of practice.

Ziv Haskal, MD, introduces thyroid ablation, an important procedure that will increasingly be performed by interventional radiologists. 

In her presentation at CIO 2018, Dr. Brown reviewed the characteristics of the embolizing agents, the pre- and post-procedure protocols she follows, and other key tips for performing the procedure.